[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Japan Carbidopa Market Report 2016

September 2016 | 123 pages | ID: JB4C57ED45CEN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Carbidopa

Revenue, means the sales value of Carbidopa

This report studies sales (consumption) of Carbidopa in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Novartis
  • Merck Sharp & Dohme Corp
  • AbbVie
  • Impax
  • WOCKHARDT
  • Allergan
  • Teva Pharmaceuticals
  • Mylan N.V.
  • Valeant
  • Jinghua Pharmaceutical
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Carbidopa in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Japan Carbidopa Market Report 2016

1 CARBIDOPA OVERVIEW

1.1 Product Overview and Scope of Carbidopa
1.2 Classification of Carbidopa
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Carbidopa
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Carbidopa (2011-2021)
  1.4.1 Japan Carbidopa Sales and Growth Rate (2011-2021)
  1.4.2 Japan Carbidopa Revenue and Growth Rate (2011-2021)

2 JAPAN CARBIDOPA COMPETITION BY MANUFACTURERS

2.1 Japan Carbidopa Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 Japan Carbidopa Revenue and Share by Manufactures (2015 and 2016)
2.3 Japan Carbidopa Average Price by Manufactures (2015 and 2016)
2.4 Carbidopa Market Competitive Situation and Trends
  2.4.1 Carbidopa Market Concentration Rate
  2.4.2 Carbidopa Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 JAPAN CARBIDOPA SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 Japan Carbidopa Sales and Market Share by Type (2011-2016)
3.2 Japan Carbidopa Revenue and Market Share by Type (2011-2016)
3.3 Japan Carbidopa Price by Type (2011-2016)
3.4 Japan Carbidopa Sales Growth Rate by Type (2011-2016)

4 JAPAN CARBIDOPA SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 Japan Carbidopa Sales and Market Share by Application (2011-2016)
4.2 Japan Carbidopa Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 JAPAN CARBIDOPA MANUFACTURERS PROFILES/ANALYSIS

5.1 Novartis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Carbidopa Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Novartis Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Merck Sharp & Dohme Corp
  5.2.2 Carbidopa Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Merck Sharp & Dohme Corp Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 AbbVie
  5.3.2 Carbidopa Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 AbbVie Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Impax
  5.4.2 Carbidopa Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Impax Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 WOCKHARDT
  5.5.2 Carbidopa Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 WOCKHARDT Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Allergan
  5.6.2 Carbidopa Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Allergan Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Teva Pharmaceuticals
  5.7.2 Carbidopa Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Teva Pharmaceuticals Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Mylan N.V.
  5.8.2 Carbidopa Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Mylan N.V. Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Valeant
  5.9.2 Carbidopa Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Valeant Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Jinghua Pharmaceutical
  5.10.2 Carbidopa Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Jinghua Pharmaceutical Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 CARBIDOPA MANUFACTURING COST ANALYSIS

6.1 Carbidopa Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Carbidopa

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Carbidopa Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Carbidopa Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 JAPAN CARBIDOPA MARKET FORECAST (2016-2021)

10.1 Japan Carbidopa Sales, Revenue Forecast (2016-2021)
10.2 Japan Carbidopa Sales Forecast by Type (2016-2021)
10.3 Japan Carbidopa Sales Forecast by Application (2016-2021)
10.4 Carbidopa Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Carbidopa
Table Classification of Carbidopa
Figure Japan Sales Market Share of Carbidopa by Type in 2015
Table Application of Carbidopa
Figure Japan Sales Market Share of Carbidopa by Application in 2015
Figure Japan Carbidopa Sales and Growth Rate (2011-2021)
Figure Japan Carbidopa Revenue and Growth Rate (2011-2021)
Table Japan Carbidopa Sales of Key Manufacturers (2015 and 2016)
Table Japan Carbidopa Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Carbidopa Sales Share by Manufacturers
Figure 2016 Carbidopa Sales Share by Manufacturers
Table Japan Carbidopa Revenue by Manufacturers (2015 and 2016)
Table Japan Carbidopa Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Japan Carbidopa Revenue Share by Manufacturers
Table 2016 Japan Carbidopa Revenue Share by Manufacturers
Table Japan Market Carbidopa Average Price of Key Manufacturers (2015 and 2016)
Figure Japan Market Carbidopa Average Price of Key Manufacturers in 2015
Figure Carbidopa Market Share of Top 3 Manufacturers
Figure Carbidopa Market Share of Top 5 Manufacturers
Table Japan Carbidopa Sales by Type (2011-2016)
Table Japan Carbidopa Sales Share by Type (2011-2016)
Figure Japan Carbidopa Sales Market Share by Type in 2015
Table Japan Carbidopa Revenue and Market Share by Type (2011-2016)
Table Japan Carbidopa Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Carbidopa by Type (2011-2016)
Table Japan Carbidopa Price by Type (2011-2016)
Figure Japan Carbidopa Sales Growth Rate by Type (2011-2016)
Table Japan Carbidopa Sales by Application (2011-2016)
Table Japan Carbidopa Sales Market Share by Application (2011-2016)
Figure Japan Carbidopa Sales Market Share by Application in 2015
Table Japan Carbidopa Sales Growth Rate by Application (2011-2016)
Figure Japan Carbidopa Sales Growth Rate by Application (2011-2016)
Table Novartis Basic Information List
Table Novartis Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Carbidopa Sales Market Share (2011-2016)
Table Merck Sharp & Dohme Corp Basic Information List
Table Merck Sharp & Dohme Corp Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Sharp & Dohme Corp Carbidopa Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Carbidopa Sales Market Share (2011-2016)
Table Impax Basic Information List
Table Impax Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Table Impax Carbidopa Sales Market Share (2011-2016)
Table WOCKHARDT Basic Information List
Table WOCKHARDT Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Table WOCKHARDT Carbidopa Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Carbidopa Sales Market Share (2011-2016)
Table Teva Pharmaceuticals Basic Information List
Table Teva Pharmaceuticals Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceuticals Carbidopa Sales Market Share (2011-2016)
Table Mylan N.V. Basic Information List
Table Mylan N.V. Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan N.V. Carbidopa Sales Market Share (2011-2016)
Table Valeant Basic Information List
Table Valeant Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Carbidopa Sales Market Share (2011-2016)
Table Jinghua Pharmaceutical Basic Information List
Table Jinghua Pharmaceutical Carbidopa Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jinghua Pharmaceutical Carbidopa Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Carbidopa
Figure Manufacturing Process Analysis of Carbidopa
Figure Carbidopa Industrial Chain Analysis
Table Raw Materials Sources of Carbidopa Major Manufacturers in 2015
Table Major Buyers of Carbidopa
Table Distributors/Traders List
Figure Japan Carbidopa Production and Growth Rate Forecast (2016-2021)
Figure Japan Carbidopa Revenue and Growth Rate Forecast (2016-2021)
Table Japan Carbidopa Production Forecast by Type (2016-2021)
Table Japan Carbidopa Consumption Forecast by Application (2016-2021)


More Publications